The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 533-544

  Schoppel, Konrad ^b   Kropff, Barbara ^b   Schmidt, Christian ^b   Vornhagen, Rolf ^b   Mach, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL;

EID: 0031016170     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.533     Document Type: Article

References (11)

1. Ho M. Cytomegalovirus. Biology and infection. New York: Plenum Medical Book, 1993.
2. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12(suppl 7):754-66.
3. Schooley RT. Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev Infect Dis 1990; 12(suppl 7):811-9.
4. Reusser P. Cytomegalovirus infection and disease after bone marrow transplantation: epidemiology, prevention, and treatment. Bone Marrow Transplant 1991;7(suppl 3):52-6.
5. Adler SP, Starr SE, Plotkin SA, et al. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 1995;171:26-32.
6. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7.
7. Tanaka A, Moriuchi H, Hirota K, Numazaki Y. Neutralizing antibody response to cytomegalovirus in seropositive pregnant women. J Med Virol 1991;34:85-8.
8. Zaia JA. Prevention and treatment of Cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 1993; 17(suppl 2):392-9.
9. Jonjic S, Pavic I, Polie B, Crnkovic I, Lucin P, Koszinowski UH. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994;179:1713-7.
10. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994;179:185-93.
11. Rapp M, Messerle M, Lucin P, Koszinowski UH. In vivo protection studies with MCMV glycoproteins gB and gH expressed by vaccinia virus. In: Michelson S, Plotkin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Excerpta Medica, 1993:327.